← SynDRA
TOSEDOSTAT
SynDRA canonical compound SYN0030049 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | NPEPPS |
|---|
| Mechanism of action | Peptidase inhibitor |
|---|
All known targets
- NPEPPS
- ANPEP
- LAP3
- METAP1D
- XPNPEP2
- XPNPEP1
- RNPEPL1
- RNPEP
- NPEPL1
- METAP2
- METAP1
- AOPEP
Mechanisms of action (all sources)
- Peptidase inhibitor
- ANPEP INHIBITOR
- Aminopeptidase inhibitor
- NPEPPS INHIBITOR
- RNPEP INHIBITOR
- METAP1 INHIBITOR
- LNPEP INHIBITOR
- DNPEP INHIBITOR
- ENPEP INHIBITOR
- XPNPEP1 INHIBITOR
- LAP3 INHIBITOR
- METAP2 INHIBITOR
Drug classes
Cross-references
Synonyms
- CHR-2797
- CHR2797
- Tosedostat, CHR2797, CHR-2797
- Tosedostat (CHR2797)
- KZK563J2UW
- UNII-KZK563J2UW
- (S)-cyclopentyl 2-((R)-2-((S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl)-4-methylpentanamido)-2-phenylacetate
- cyclopentyl (S)-2-((R)-2-((S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl)-4-methylpentanamido)-2-phenylacetate
- Tosedostat [INN]
- Tosedostat [USAN:INN]
- BB-76163
- Tosedostat (USAN/INN)
- TOSEDOSTAT [USAN]
- CHR-2797(Tosedostat)
- CHR-2797; Tosedostat
- CHR2797 - Tosedostat
- TOSEDOSTAT [WHO-DD]
- MLS006011104
- CHEMBL2103847
- SCHEMBL19236550
- CHEBI:95044
- DTXSID60178577
- BCPP000283
- HMS3414A15
- HMS3678A15
- EX-A2628
- BDBM50277143
- NSC806020
- ZINC13914293
- AKOS024457707
- AT25061
- BCP9000524
- DB11781
- NSC-806020
- NCGC00263175-01
- AC-35830
- AS-55983
- HY-14807
Look up TOSEDOSTAT in the interactive SynDRA portal →